New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
07:07 EDTCRISCuris announces IND filing to initiate Erivedge Phase 2 study
Curis announced that Roche has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a multicenter, Phase 2 clinical study of Erivedge, or vismodegib, in patients with idiopathic pulmonary fibrosis. Roche and Genentech, a member of the Roche Group, develop and commercialize Erivedge under a collaboration agreement with Curis. According to Roche, following FDA review of the IND, the study is anticipated to start enrollment later this year and is expected to enroll approximately 130 patients.
News For CRIS From The Last 14 Days
Check below for free stories on CRIS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CRIS

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use